Glucagon-like peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction
This dual-peptide approach produces 15-25% weight loss - significantly superior to monotherapy - making the dosing complexity worthwhile for those seeking maximum results
A study has analyzed how plasma DPP-4 activity and levels of soluble DPP-4 correlate with inflammatory markers (C-reactive protein [CRP], IL-6, TNF-, and monocyte chemoattractant protein-1 [MCP-1]) in a subset of patients with T2DM treated with sitagliptin for 12 months as part of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS, 26)
CHRONIC WEIGHT MANAGEMENT Novo Nordisks oral semaglutide ( which may be marketed as Rybelsus at an anticipated higher dose or rebranded with a new name for weight management use ) is pending approval for chronic weight management (CWM) in Q4 of 2025
Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with (SAXENDA OR VICTOZA) [see Contraindications (4) and Warnings and Precautions (5.1)]
Hims & Hers acquired a US-based peptide facility in 2025
